New Chemical Methods for Making Medicines
Methods for Selective Organic Synthesis based on Ionic Catalysts
This project aims to create new and more precise chemical reactions to build important molecules, especially those containing fluorine, which are often used in developing new medicines.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Berkeley NIH-funded |
| Lab location | 1 site (Berkeley, United States) |
| Project ID | NIH-11129646 on NIH RePORTER |
What this research studies
This project is all about finding smarter ways to build the chemical ingredients needed for future medicines. Researchers are focusing on developing special catalysts that can precisely assemble molecules, ensuring they have the correct shape and properties. A key part of this work involves adding fluorine to molecules in a controlled way, as fluorine is a common and beneficial component in many drugs. By understanding how these reactions work at a fundamental level, the team hopes to provide chemists with better tools to create new and more effective treatments. This foundational work could speed up the discovery and development of new drugs for various health conditions.
Who could benefit from this research
Good fit: This foundational chemistry research does not directly involve patients, but future patients who could benefit from new drug discoveries might eventually be considered.
Not a fit: Patients seeking immediate treatment or direct participation in a clinical trial would not find a direct benefit from this basic chemistry development.
Why it matters
Potential benefit: If successful, this work could provide chemists with better tools to create new and more effective drug molecules, potentially leading to new treatments for various diseases.
How similar studies have performed: While the specific catalytic platforms and reactions may be novel, the broader field of developing new synthetic methods for drug discovery is an ongoing area of successful chemical research.
Where this research is happening
Berkeley, United States
- University of California Berkeley — Berkeley, United States (Active)
Researchers
- Principal investigator: Toste, F. Dean — University of California Berkeley
- Study coordinator: Toste, F. Dean
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.